 HERCULES, Calif.--BUSINESS WIRE--Bio-Rad Laboratories, Inc. NYSE: BIO and BIOb, a global leader of life science research and clinical diagnostic products, today announced a partnership with Seegene, Inc., a global leader in multiplex molecular diagnostics, for the clinical development and commercialization of infectious disease molecular diagnostic products. Under the terms of the agreement, Seegene, based in Seoul, Korea, will provide diagnostic tests for use on Bio-Rads CFX96TM Dx Real-Ti 